No Data
No Data
Express News | Deep Track Capital LP Reports 5.85% Passive Stake in Eliem Therapeutics Inc as of June 27 - SEC Filing
Express News | Eliem Therapeutics Announces Its Addition To The Russell 2000 And Russell 3000 Indexes, , Effective Today
Eliem Therapeutics Announces Its Addition to the Russell 2000 and Russell 3000 Indexes
SEATTLE and CAMBRIDGE, United Kingdom, June 28, 2024 (GLOBE NEWSWIRE) -- Eliem Therapeutics, Inc. (NASDAQ:ELYM), announced today that the Company will be included in the Russell 2000 Index and the broad-market
Express News | Eliem Therapeutics Inc - Appointment of Aoife Brennan as President and Chief Executive Officer
Eliem Therapeutics Names Dr. Stephen Thomas, Former Tenet CEO, to the Board
Eliem Therapeutics Names Dr. Stephen Thomas, Former Tenet CEO, to the Board
Eliem Therapeutics Names Dr. Jan Hillson as Senior Clinical Adviser
Eliem Therapeutics Names Dr. Jan Hillson as Senior Clinical Adviser